Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth

References

• MacDougald OA, Burant CF. The rapidly expanding family of adipokines. Cell Metab 2007; 6:159 - 61; http://dx.doi.org/10.1016/j.cmet.2007.08.010; PMID: 17767903
   PubMed Web of Science ®Google Scholar
• Andò S, Catalano S. The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol 2012; 8:263 - 75; http://dx.doi.org/10.1038/nrendo.2011.184; PMID: 22083089
   PubMed Web of Science ®Google Scholar
• Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine 2010; 37:11 - 32; http://dx.doi.org/10.1007/s12020-009-9278-8; PMID: 20963555
   PubMed Web of Science ®Google Scholar
• Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147:173 - 80; http://dx.doi.org/10.1530/eje.0.1470173; PMID: 12153737
   PubMed Web of Science ®Google Scholar
• Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46:459 - 69; PMID: 12687327
   PubMed Web of Science ®Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930 - 5; http://dx.doi.org/10.1210/jc.86.5.1930; PMID: 11344187
   PubMed Web of Science ®Google Scholar
• Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277:25863 - 6; http://dx.doi.org/10.1074/jbc.C200251200; PMID: 12032136
   PubMed Web of Science ®Google Scholar
• Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8:731 - 7; http://dx.doi.org/10.1038/nm724; PMID: 12068289
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6:772 - 83; http://dx.doi.org/10.1038/nri1937; PMID: 16998510
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev 2012; 33:547 - 94; http://dx.doi.org/10.1210/er.2011-1015; PMID: 22547160
   PubMed Web of Science ®Google Scholar
• Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001; 98:2005 - 10; http://dx.doi.org/10.1073/pnas.98.4.2005; PMID: 11172066
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423:762 - 9; http://dx.doi.org/10.1038/nature01705; PMID: 12802337
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26:439 - 51; http://dx.doi.org/10.1210/er.2005-0005; PMID: 15897298
   PubMed Web of Science ®Google Scholar
• Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, Fang Q, Christ-Roberts CY, Hong JY, Kim RY, et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 2006; 8:516 - 23; http://dx.doi.org/10.1038/ncb1404; PMID: 16622416
   PubMed Web of Science ®Google Scholar
• Lee M-H, Klein RL, El-Shewy HM, Luttrell DK, Luttrell LM. The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry 2008; 47:11682 - 92; http://dx.doi.org/10.1021/bi801451f; PMID: 18842004
   PubMed Web of Science ®Google Scholar
• Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006; 94:1221 - 5; http://dx.doi.org/10.1038/sj.bjc.6603051; PMID: 16570048
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003; 9:5699 - 704; PMID: 14654554
   PubMed Web of Science ®Google Scholar
• Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004; 89:1102 - 7; http://dx.doi.org/10.1210/jc.2003-031804; PMID: 15001594
   PubMed Web of Science ®Google Scholar
• Körner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 2007; 92:1041 - 8; http://dx.doi.org/10.1210/jc.2006-1858; PMID: 17192291
   PubMed Web of Science ®Google Scholar
• Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, Roh YK. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 2005; 28:1263 - 9; http://dx.doi.org/10.1007/BF02978210; PMID: 16350853
   PubMed Web of Science ®Google Scholar
• Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, Pecquery R. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 2008; 20:971 - 7; PMID: 18813842
   PubMed Web of Science ®Google Scholar
• Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 2008; 98:370 - 9; http://dx.doi.org/10.1038/sj.bjc.6604166; PMID: 18182989
   PubMed Web of Science ®Google Scholar
• Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2006; 345:271 - 9; http://dx.doi.org/10.1016/j.bbrc.2006.04.076; PMID: 16678125
   PubMed Web of Science ®Google Scholar
• Jardé T, Caldefie-Chézet F, Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F, Vasson MP. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer 2009; 16:1197 - 210; http://dx.doi.org/10.1677/ERC-09-0043; PMID: 19661131
   PubMed Web of Science ®Google Scholar
• Treeck O, Lattrich C, Juhasz-Boess I, Buchholz S, Pfeiler G, Ortmann O. Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br J Cancer 2008; 99:1246 - 50; http://dx.doi.org/10.1038/sj.bjc.6604692; PMID: 18827813
   PubMed Web of Science ®Google Scholar
• Pfeiler GH, Buechler C, Neumeier M, Schäffler A, Schmitz G, Ortmann O, Treeck O. Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol. Oncol Rep 2008; 19:787 - 93; PMID: 18288417
   PubMed Web of Science ®Google Scholar
• Landskroner-Eiger S, Qian B, Muise ES, Nawrocki AR, Berger JP, Fine EJ, Koba W, Deng Y, Pollard JW, Scherer PE. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res 2009; 15:3265 - 76; http://dx.doi.org/10.1158/1078-0432.CCR-08-2649; PMID: 19447867
   PubMed Web of Science ®Google Scholar
• Sflomos G, Brisken C. A new Achilles Heel in breast cancer?. Oncotarget 2013; 4:1126 - 7; PMID: 23907591
   PubMed Web of Science ®Google Scholar
• Mauro L, Surmacz E. IGF-I receptor, cell-cell adhesion, tumour development and progression. J Mol Histol 2004; 35:247 - 53; http://dx.doi.org/10.1023/B:HIJO.0000032356.98363.a2; PMID: 15339044
   PubMed Web of Science ®Google Scholar
• Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003; 148:281 - 92; http://dx.doi.org/10.1530/eje.0.1480281; PMID: 12611608
   PubMed Web of Science ®Google Scholar
• Schäffler A, Schölmerich J, Buechler C. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab 2007; 3:345 - 54; http://dx.doi.org/10.1038/ncpendmet0456; PMID: 17377617
   PubMedGoogle Scholar
• Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev 2011; 32:550 - 70; http://dx.doi.org/10.1210/er.2010-0030; PMID: 21642230
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548 - 56; http://dx.doi.org/10.1210/jc.2004-0395; PMID: 15181022
   PubMed Web of Science ®Google Scholar
• Trujillo ME, Scherer PE. Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257:167 - 75; http://dx.doi.org/10.1111/j.1365-2796.2004.01426.x; PMID: 15656875
   PubMed Web of Science ®Google Scholar
• Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 2011; 47:33 - 43; http://dx.doi.org/10.1016/j.ejca.2010.09.005; PMID: 20889333
   PubMed Web of Science ®Google Scholar
• Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A. Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 2006; 66:11462 - 70; http://dx.doi.org/10.1158/0008-5472.CAN-06-1969; PMID: 17145894
   PubMed Web of Science ®Google Scholar
• Chen X, Wang Y. Adiponectin and breast cancer. Med Oncol 2011; 28:1288 - 95; http://dx.doi.org/10.1007/s12032-010-9617-x; PMID: 20625941
   PubMed Web of Science ®Google Scholar
• Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, Andò S, Sisci D. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr Cancer Drug Targets 2008; 8:597 - 610; http://dx.doi.org/10.2174/156800908786241104; PMID: 18991569
   PubMed Web of Science ®Google Scholar
• Song RX, Chen Y, Zhang Z, Bao Y, Yue W, Wang JP, Fan P, Santen RJ. Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells. J Steroid Biochem Mol Biol 2010; 118:219 - 30; http://dx.doi.org/10.1016/j.jsbmb.2009.09.018; PMID: 19815064
   PubMed Web of Science ®Google Scholar
• Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001; 22:153 - 83; http://dx.doi.org/10.1210/er.22.2.153; PMID: 11294822
   PubMed Web of Science ®Google Scholar
• Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 2009; 296:E22 - 36; http://dx.doi.org/10.1152/ajpendo.90731.2008; PMID: 18854421
   PubMed Web of Science ®Google Scholar
• Murphy LC, Weitsman GE, Skliris GP, Teh EM, Li L, Peng B, Davie JR, Ung K, Niu YL, Troup S, et al. Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo. J Steroid Biochem Mol Biol 2006; 102:139 - 46; http://dx.doi.org/10.1016/j.jsbmb.2006.09.021; PMID: 17092701
   PubMed Web of Science ®Google Scholar
• Luttrell LM. ‘Location, location, location’: activation and targeting of MAP kinases by G protein-coupled receptors. J Mol Endocrinol 2003; 30:117 - 26; http://dx.doi.org/10.1677/jme.0.0300117; PMID: 12683936
   PubMed Web of Science ®Google Scholar
• De Amicis F, Russo A, Avena P, Santoro M, Vivacqua A, Bonofiglio D, Mauro L, Aquila S, Tramontano D, Fuqua SA, et al. In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells. Mol Nutr Food Res 2013; 57:840 - 53; http://dx.doi.org/10.1002/mnfr.201200560; PMID: 23322423
   PubMed Web of Science ®Google Scholar
• Rovito D, Giordano C, Vizza D, Plastina P, Barone I, Casaburi I, Lanzino M, De Amicis F, Sisci D, Mauro L, et al. Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells. J Cell Physiol 2013; 228:1314 - 22; http://dx.doi.org/10.1002/jcp.24288; PMID: 23168911
   PubMed Web of Science ®Google Scholar
• Panno ML, Giordano F, Rizza P, Pellegrino M, Zito D, Giordano C, Mauro L, Catalano S, Aquila S, Sisci D, et al. Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination. Breast Cancer Res Treat 2012; 136:443 - 55; http://dx.doi.org/10.1007/s10549-012-2282-3; PMID: 23053665
   PubMed Web of Science ®Google Scholar
• Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I, Andò S. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res 2007; 67:3412 - 21; http://dx.doi.org/10.1158/0008-5472.CAN-06-2890; PMID: 17409452
   PubMed Web of Science ®Google Scholar
• Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I, Giordano F, Casaburi I, Catalano S, De Amicis F, et al. Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle 2012; 11:2911 - 21; http://dx.doi.org/10.4161/cc.21336; PMID: 22810004
   PubMed Web of Science ®Google Scholar
• Mauro L, Pellegrino M, Lappano R, Vivacqua A, Giordano F, Palma MG, Andò S, Maggiolini M. E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor. Breast Cancer Res Treat 2010; 121:79 - 89; http://dx.doi.org/10.1007/s10549-009-0456-4; PMID: 19593637
   PubMed Web of Science ®Google Scholar
• Guido C, Whitaker-Menezes D, Lin Z, Pestell RG, Howell A, Zimmers TA, Casimiro MC, Aquila S, Ando’ S, Martinez-Outschoorn UE, et al. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget 2012; 3:798 - 810; PMID: 22878233
   PubMed Web of Science ®Google Scholar
• De Amicis F, Zupo S, Panno ML, Malivindi R, Giordano F, Barone I, Mauro L, Fuqua SA, Andò S. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter. Mol Endocrinol 2009; 23:454 - 65; http://dx.doi.org/10.1210/me.2008-0267; PMID: 19147702
   PubMed Web of Science ®Google Scholar
• Casaburi I, Avena P, Lanzino M, Sisci D, Giordano F, Maris P, Catalano S, Morelli C, Andò S. Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation. Cell Cycle 2012; 11:2699 - 710; http://dx.doi.org/10.4161/cc.21029; PMID: 22751440
   PubMed Web of Science ®Google Scholar